Aldosterone-specific_JJ
membrane_NN
receptors_NNS
and_CC
rapid_JJ
non-genomic_JJ
actions_NNS
of_IN
mineralocorticoids_NNS
._.

Functional_JJ
studies_NNS
in_IN
extrarenal_JJ
,_,
non-epithelial_JJ
cells_NNS
such_JJ
as_IN
smooth_JJ
muscle_NN
cells_NNS
and_CC
more_RBR
recently_RB
circulating_VBG
human_JJ
lymphocytes_NNS
have_VBP
provided_VBN
increasing_VBG
evidence_NN
that_IN
aldosterone_NN
produces_VBZ
not_RB
only_RB
classical_JJ
genomic_JJ
effects_NNS
,_,
but_CC
also_RB
rapid_JJ
,_,
non-genomic_JJ
effects_NNS
on_IN
transmembrane_JJ
electrolyte_NN
movements_NNS
._.

These_DT
involve_VBP
activation_NN
of_IN
the_DT
sodium\/proton_JJ
exchanger_NN
of_IN
the_DT
cell_NN
membrane_NN
at_IN
very_RB
low_JJ
,_,
physiological_JJ
concentrations_NNS
of_IN
aldosterone_NN
with_IN
an_DT
acute_JJ
onset_NN
within_IN
1-2_CD
min_NN
._.

A_DT
second_JJ
messenger_NN
cascade_NN
involved_VBN
is_VBZ
the_DT
inositol_JJ
1,4,5-trisphosphate_NN
\/_:
calcium_NN
pathway_NN
which_WDT
responds_VBZ
over_IN
the_DT
same_JJ
rapid_JJ
time_NN
course_NN
._.

Such_JJ
changes_NNS
clearly_RB
can_MD
not_RB
be_VB
explained_VBN
by_IN
genomic_JJ
mechanisms_NNS
,_,
which_WDT
are_VBP
responsible_JJ
for_IN
later_JJ
effects_NNS
than_IN
the_DT
membrane_NN
related_JJ
rapid_JJ
responses_NNS
._.

The_DT
mechanisms_NNS
underlying_VBG
these_DT
rapid_JJ
effects_NNS
of_IN
aldosterone_NN
on_IN
electrolytes_NNS
have_VBP
been_VBN
extensively_RB
studied_VBN
in_IN
human_JJ
lymphocytes_NNS
,_,
which_WDT
thus_RB
may_MD
represent_VB
valuable_JJ
tools_NNS
in_IN
the_DT
delineation_NN
of_IN
the_DT
receptor-effector_JJ
mechanisms_NNS
involved_VBN
._.

The_DT
unique_JJ
characteristics_NNS
of_IN
this_DT
new_JJ
pathway_NN
for_IN
steroid_NN
action_NN
include_VBP
its_PRP$
rapid_JJ
time_NN
course_NN
,_,
10,000-fold_JJ
selectivity_NN
for_IN
aldosterone_NN
over_IN
cortisol_NN
and_CC
the_DT
ineffectiveness_NN
of_IN
spironolactones_NNS
,_,
classical_JJ
mineralocorticoid_NN
antagonists_NNS
,_,
as_IN
antagonists_NNS
of_IN
the_DT
response_NN
._.

